0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antibody-drug Conjugates Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-31N9042
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Antibody drug Conjugates Market Insights and Forecast to 2028

Global Antibody-drug Conjugates Market Insights and Forecast to 2028

Code: QYRE-Auto-31N9042
Report
January 2022
75 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
Market Analysis and Insights: Global Antibody-drug Conjugates Market

Due to the COVID-19 pandemic, the global Antibody-drug Conjugates market size is estimated to be worth US$ 2975.7 million in 2022 and is forecast to a readjusted size of US$ 3919.8 million by 2028 with a CAGR of 4.7% during the review period.

Fully considering the economic change by this health crisis, Adcetris accounting for % of the Antibody-drug Conjugates global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Breast Cancer segment is altered to an % CAGR throughout this forecast period.
North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.

The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.

Global Antibody-drug Conjugates Scope and Segment
Antibody-drug Conjugates market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Antibody-drug Conjugates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Adcetris
Kadcyla

Segment by Application

Breast Cancer
Lymphoma

BY COMPANY

ImmunoGen
Seattle Genetics
Roche
Takeda

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
1 Study Coverage
1.1 Antibody-drug Conjugates Product Introduction
1.2 Market by Type
1.2.1 Global Antibody-drug Conjugates Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Adcetris
1.2.3 Kadcyla
1.3 Market by Application
1.3.1 Global Antibody-drug Conjugates Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antibody-drug Conjugates Sales Estimates and Forecasts 2017-2028
2.2 Global Antibody-drug Conjugates Revenue Estimates and Forecasts 2017-2028
2.3 Global Antibody-drug Conjugates Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antibody-drug Conjugates Sales by Region
2.4.1 Global Antibody-drug Conjugates Sales by Region (2017-2022)
2.4.2 Global Sales Antibody-drug Conjugates by Region (2023-2028)
2.5 Global Antibody-drug Conjugates Revenue by Region
2.5.1 Global Antibody-drug Conjugates Revenue by Region (2017-2022)
2.5.2 Global Antibody-drug Conjugates Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antibody-drug Conjugates Sales by Manufacturers
3.1.1 Global Top Antibody-drug Conjugates Manufacturers by Sales (2017-2022)
3.1.2 Global Antibody-drug Conjugates Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antibody-drug Conjugates in 2021
3.2 Global Antibody-drug Conjugates Revenue by Manufacturers
3.2.1 Global Antibody-drug Conjugates Revenue by Manufacturers (2017-2022)
3.2.2 Global Antibody-drug Conjugates Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antibody-drug Conjugates Revenue in 2021
3.3 Global Antibody-drug Conjugates Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antibody-drug Conjugates Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antibody-drug Conjugates Sales by Type
4.1.1 Global Antibody-drug Conjugates Historical Sales by Type (2017-2022)
4.1.2 Global Antibody-drug Conjugates Forecasted Sales by Type (2023-2028)
4.1.3 Global Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
4.2 Global Antibody-drug Conjugates Revenue by Type
4.2.1 Global Antibody-drug Conjugates Historical Revenue by Type (2017-2022)
4.2.2 Global Antibody-drug Conjugates Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antibody-drug Conjugates Revenue Market Share by Type (2017-2028)
4.3 Global Antibody-drug Conjugates Price by Type
4.3.1 Global Antibody-drug Conjugates Price by Type (2017-2022)
4.3.2 Global Antibody-drug Conjugates Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antibody-drug Conjugates Sales by Application
5.1.1 Global Antibody-drug Conjugates Historical Sales by Application (2017-2022)
5.1.2 Global Antibody-drug Conjugates Forecasted Sales by Application (2023-2028)
5.1.3 Global Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
5.2 Global Antibody-drug Conjugates Revenue by Application
5.2.1 Global Antibody-drug Conjugates Historical Revenue by Application (2017-2022)
5.2.2 Global Antibody-drug Conjugates Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antibody-drug Conjugates Revenue Market Share by Application (2017-2028)
5.3 Global Antibody-drug Conjugates Price by Application
5.3.1 Global Antibody-drug Conjugates Price by Application (2017-2022)
5.3.2 Global Antibody-drug Conjugates Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antibody-drug Conjugates Market Size by Type
6.1.1 North America Antibody-drug Conjugates Sales by Type (2017-2028)
6.1.2 North America Antibody-drug Conjugates Revenue by Type (2017-2028)
6.2 North America Antibody-drug Conjugates Market Size by Application
6.2.1 North America Antibody-drug Conjugates Sales by Application (2017-2028)
6.2.2 North America Antibody-drug Conjugates Revenue by Application (2017-2028)
6.3 North America Antibody-drug Conjugates Market Size by Country
6.3.1 North America Antibody-drug Conjugates Sales by Country (2017-2028)
6.3.2 North America Antibody-drug Conjugates Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antibody-drug Conjugates Market Size by Type
7.1.1 Europe Antibody-drug Conjugates Sales by Type (2017-2028)
7.1.2 Europe Antibody-drug Conjugates Revenue by Type (2017-2028)
7.2 Europe Antibody-drug Conjugates Market Size by Application
7.2.1 Europe Antibody-drug Conjugates Sales by Application (2017-2028)
7.2.2 Europe Antibody-drug Conjugates Revenue by Application (2017-2028)
7.3 Europe Antibody-drug Conjugates Market Size by Country
7.3.1 Europe Antibody-drug Conjugates Sales by Country (2017-2028)
7.3.2 Europe Antibody-drug Conjugates Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antibody-drug Conjugates Market Size by Type
8.1.1 Asia Pacific Antibody-drug Conjugates Sales by Type (2017-2028)
8.1.2 Asia Pacific Antibody-drug Conjugates Revenue by Type (2017-2028)
8.2 Asia Pacific Antibody-drug Conjugates Market Size by Application
8.2.1 Asia Pacific Antibody-drug Conjugates Sales by Application (2017-2028)
8.2.2 Asia Pacific Antibody-drug Conjugates Revenue by Application (2017-2028)
8.3 Asia Pacific Antibody-drug Conjugates Market Size by Region
8.3.1 Asia Pacific Antibody-drug Conjugates Sales by Region (2017-2028)
8.3.2 Asia Pacific Antibody-drug Conjugates Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antibody-drug Conjugates Market Size by Type
9.1.1 Latin America Antibody-drug Conjugates Sales by Type (2017-2028)
9.1.2 Latin America Antibody-drug Conjugates Revenue by Type (2017-2028)
9.2 Latin America Antibody-drug Conjugates Market Size by Application
9.2.1 Latin America Antibody-drug Conjugates Sales by Application (2017-2028)
9.2.2 Latin America Antibody-drug Conjugates Revenue by Application (2017-2028)
9.3 Latin America Antibody-drug Conjugates Market Size by Country
9.3.1 Latin America Antibody-drug Conjugates Sales by Country (2017-2028)
9.3.2 Latin America Antibody-drug Conjugates Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antibody-drug Conjugates Market Size by Type
10.1.1 Middle East and Africa Antibody-drug Conjugates Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antibody-drug Conjugates Revenue by Type (2017-2028)
10.2 Middle East and Africa Antibody-drug Conjugates Market Size by Application
10.2.1 Middle East and Africa Antibody-drug Conjugates Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antibody-drug Conjugates Revenue by Application (2017-2028)
10.3 Middle East and Africa Antibody-drug Conjugates Market Size by Country
10.3.1 Middle East and Africa Antibody-drug Conjugates Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antibody-drug Conjugates Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 ImmunoGen
11.1.1 ImmunoGen Corporation Information
11.1.2 ImmunoGen Overview
11.1.3 ImmunoGen Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 ImmunoGen Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ImmunoGen Recent Developments
11.2 Seattle Genetics
11.2.1 Seattle Genetics Corporation Information
11.2.2 Seattle Genetics Overview
11.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Seattle Genetics Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Seattle Genetics Recent Developments
11.3 Roche
11.3.1 Roche Corporation Information
11.3.2 Roche Overview
11.3.3 Roche Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Roche Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Roche Recent Developments
11.4 Takeda
11.4.1 Takeda Corporation Information
11.4.2 Takeda Overview
11.4.3 Takeda Antibody-drug Conjugates Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Takeda Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Takeda Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antibody-drug Conjugates Industry Chain Analysis
12.2 Antibody-drug Conjugates Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antibody-drug Conjugates Production Mode & Process
12.4 Antibody-drug Conjugates Sales and Marketing
12.4.1 Antibody-drug Conjugates Sales Channels
12.4.2 Antibody-drug Conjugates Distributors
12.5 Antibody-drug Conjugates Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antibody-drug Conjugates Industry Trends
13.2 Antibody-drug Conjugates Market Drivers
13.3 Antibody-drug Conjugates Market Challenges
13.4 Antibody-drug Conjugates Market Restraints
14 Key Findings in The Global Antibody-drug Conjugates Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Antibody-drug Conjugates Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Adcetris
    Table 3. Major Manufacturers of Kadcyla
    Table 4. Global Antibody-drug Conjugates Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Antibody-drug Conjugates Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Antibody-drug Conjugates Sales by Region (2017-2022) & (Kg)
    Table 7. Global Antibody-drug Conjugates Sales Market Share by Region (2017-2022)
    Table 8. Global Antibody-drug Conjugates Sales by Region (2023-2028) & (Kg)
    Table 9. Global Antibody-drug Conjugates Sales Market Share by Region (2023-2028)
    Table 10. Global Antibody-drug Conjugates Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Antibody-drug Conjugates Revenue Market Share by Region (2017-2022)
    Table 12. Global Antibody-drug Conjugates Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Antibody-drug Conjugates Revenue Market Share by Region (2023-2028)
    Table 14. Global Antibody-drug Conjugates Sales by Manufacturers (2017-2022) & (Kg)
    Table 15. Global Antibody-drug Conjugates Sales Share by Manufacturers (2017-2022)
    Table 16. Global Antibody-drug Conjugates Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Antibody-drug Conjugates Revenue Share by Manufacturers (2017-2022)
    Table 18. Antibody-drug Conjugates Price by Manufacturers (2017-2022) &(USD/Kg)
    Table 19. Global Antibody-drug Conjugates Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Antibody-drug Conjugates by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody-drug Conjugates as of 2021)
    Table 21. Antibody-drug Conjugates Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Antibody-drug Conjugates Product Offered
    Table 23. Date of Manufacturers Enter into Antibody-drug Conjugates Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
    Table 26. Global Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
    Table 27. Global Antibody-drug Conjugates Sales Share by Type (2017-2022)
    Table 28. Global Antibody-drug Conjugates Sales Share by Type (2023-2028)
    Table 29. Global Antibody-drug Conjugates Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Antibody-drug Conjugates Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Antibody-drug Conjugates Revenue Share by Type (2017-2022)
    Table 32. Global Antibody-drug Conjugates Revenue Share by Type (2023-2028)
    Table 33. Antibody-drug Conjugates Price by Type (2017-2022) & (USD/Kg)
    Table 34. Global Antibody-drug Conjugates Price Forecast by Type (2023-2028) & (USD/Kg)
    Table 35. Global Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
    Table 36. Global Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
    Table 37. Global Antibody-drug Conjugates Sales Share by Application (2017-2022)
    Table 38. Global Antibody-drug Conjugates Sales Share by Application (2023-2028)
    Table 39. Global Antibody-drug Conjugates Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Antibody-drug Conjugates Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Antibody-drug Conjugates Revenue Share by Application (2017-2022)
    Table 42. Global Antibody-drug Conjugates Revenue Share by Application (2023-2028)
    Table 43. Antibody-drug Conjugates Price by Application (2017-2022) & (USD/Kg)
    Table 44. Global Antibody-drug Conjugates Price Forecast by Application (2023-2028) & (USD/Kg)
    Table 45. North America Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
    Table 46. North America Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
    Table 47. North America Antibody-drug Conjugates Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Antibody-drug Conjugates Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
    Table 50. North America Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
    Table 51. North America Antibody-drug Conjugates Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Antibody-drug Conjugates Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Antibody-drug Conjugates Sales by Country (2017-2022) & (Kg)
    Table 54. North America Antibody-drug Conjugates Sales by Country (2023-2028) & (Kg)
    Table 55. North America Antibody-drug Conjugates Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Antibody-drug Conjugates Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
    Table 58. Europe Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
    Table 59. Europe Antibody-drug Conjugates Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Antibody-drug Conjugates Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
    Table 62. Europe Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
    Table 63. Europe Antibody-drug Conjugates Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Antibody-drug Conjugates Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Antibody-drug Conjugates Sales by Country (2017-2022) & (Kg)
    Table 66. Europe Antibody-drug Conjugates Sales by Country (2023-2028) & (Kg)
    Table 67. Europe Antibody-drug Conjugates Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Antibody-drug Conjugates Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
    Table 70. Asia Pacific Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
    Table 71. Asia Pacific Antibody-drug Conjugates Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Antibody-drug Conjugates Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
    Table 74. Asia Pacific Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
    Table 75. Asia Pacific Antibody-drug Conjugates Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Antibody-drug Conjugates Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Antibody-drug Conjugates Sales by Region (2017-2022) & (Kg)
    Table 78. Asia Pacific Antibody-drug Conjugates Sales by Region (2023-2028) & (Kg)
    Table 79. Asia Pacific Antibody-drug Conjugates Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Antibody-drug Conjugates Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
    Table 82. Latin America Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
    Table 83. Latin America Antibody-drug Conjugates Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Antibody-drug Conjugates Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
    Table 86. Latin America Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
    Table 87. Latin America Antibody-drug Conjugates Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Antibody-drug Conjugates Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Antibody-drug Conjugates Sales by Country (2017-2022) & (Kg)
    Table 90. Latin America Antibody-drug Conjugates Sales by Country (2023-2028) & (Kg)
    Table 91. Latin America Antibody-drug Conjugates Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Antibody-drug Conjugates Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Antibody-drug Conjugates Sales by Type (2017-2022) & (Kg)
    Table 94. Middle East and Africa Antibody-drug Conjugates Sales by Type (2023-2028) & (Kg)
    Table 95. Middle East and Africa Antibody-drug Conjugates Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Antibody-drug Conjugates Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Antibody-drug Conjugates Sales by Application (2017-2022) & (Kg)
    Table 98. Middle East and Africa Antibody-drug Conjugates Sales by Application (2023-2028) & (Kg)
    Table 99. Middle East and Africa Antibody-drug Conjugates Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Antibody-drug Conjugates Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Antibody-drug Conjugates Sales by Country (2017-2022) & (Kg)
    Table 102. Middle East and Africa Antibody-drug Conjugates Sales by Country (2023-2028) & (Kg)
    Table 103. Middle East and Africa Antibody-drug Conjugates Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Antibody-drug Conjugates Revenue by Country (2023-2028) & (US$ Million)
    Table 105. ImmunoGen Corporation Information
    Table 106. ImmunoGen Description and Major Businesses
    Table 107. ImmunoGen Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 108. ImmunoGen Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. ImmunoGen Recent Developments
    Table 110. Seattle Genetics Corporation Information
    Table 111. Seattle Genetics Description and Major Businesses
    Table 112. Seattle Genetics Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 113. Seattle Genetics Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Seattle Genetics Recent Developments
    Table 115. Roche Corporation Information
    Table 116. Roche Description and Major Businesses
    Table 117. Roche Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 118. Roche Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Roche Recent Developments
    Table 120. Takeda Corporation Information
    Table 121. Takeda Description and Major Businesses
    Table 122. Takeda Antibody-drug Conjugates Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
    Table 123. Takeda Antibody-drug Conjugates Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Takeda Recent Developments
    Table 125. Key Raw Materials Lists
    Table 126. Raw Materials Key Suppliers Lists
    Table 127. Antibody-drug Conjugates Distributors List
    Table 128. Antibody-drug Conjugates Customers List
    Table 129. Antibody-drug Conjugates Market Trends
    Table 130. Antibody-drug Conjugates Market Drivers
    Table 131. Antibody-drug Conjugates Market Challenges
    Table 132. Antibody-drug Conjugates Market Restraints
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Antibody-drug Conjugates Product Picture
    Figure 3. Global Antibody-drug Conjugates Market Share by Type in 2021 & 2028
    Figure 3. Adcetris Product Picture
    Figure 4. Kadcyla Product Picture
    Figure 5. Global Antibody-drug Conjugates Market Share by Application in 2021 & 2028
    Figure 6. Breast Cancer
    Figure 7. Lymphoma
    Figure 8. Antibody-drug Conjugates Report Years Considered
    Figure 9. Global Antibody-drug Conjugates Sales 2017-2028 (Kg)
    Figure 10. Global Antibody-drug Conjugates Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Antibody-drug Conjugates Revenue 2017-2028 (US$ Million)
    Figure 12. Global Antibody-drug Conjugates Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Antibody-drug Conjugates Sales Market Share by Region (2017-2022)
    Figure 14. Global Antibody-drug Conjugates Sales Market Share by Region (2023-2028)
    Figure 15. North America Antibody-drug Conjugates Sales YoY (2017-2028) & (Kg)
    Figure 16. North America Antibody-drug Conjugates Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Antibody-drug Conjugates Sales YoY (2017-2028) & (Kg)
    Figure 18. Europe Antibody-drug Conjugates Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Antibody-drug Conjugates Sales YoY (2017-2028) & (Kg)
    Figure 20. Asia-Pacific Antibody-drug Conjugates Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Antibody-drug Conjugates Sales YoY (2017-2028) & (Kg)
    Figure 22. Latin America Antibody-drug Conjugates Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Antibody-drug Conjugates Sales YoY (2017-2028) & (Kg)
    Figure 24. Middle East & Africa Antibody-drug Conjugates Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Antibody-drug Conjugates Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Antibody-drug Conjugates in the World: Market Share by Antibody-drug Conjugates Revenue in 2021
    Figure 27. Global Antibody-drug Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
    Figure 29. Global Antibody-drug Conjugates Revenue Market Share by Type (2017-2028)
    Figure 30. Global Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
    Figure 31. Global Antibody-drug Conjugates Revenue Market Share by Application (2017-2028)
    Figure 32. North America Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
    Figure 33. North America Antibody-drug Conjugates Revenue Market Share by Type (2017-2028)
    Figure 34. North America Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
    Figure 35. North America Antibody-drug Conjugates Revenue Market Share by Application (2017-2028)
    Figure 36. North America Antibody-drug Conjugates Sales Share by Country (2017-2028)
    Figure 37. North America Antibody-drug Conjugates Revenue Share by Country (2017-2028)
    Figure 38. U.S. Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
    Figure 41. Europe Antibody-drug Conjugates Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
    Figure 43. Europe Antibody-drug Conjugates Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Antibody-drug Conjugates Sales Share by Country (2017-2028)
    Figure 45. Europe Antibody-drug Conjugates Revenue Share by Country (2017-2028)
    Figure 46. Germany Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 47. France Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Antibody-drug Conjugates Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Antibody-drug Conjugates Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Antibody-drug Conjugates Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Antibody-drug Conjugates Revenue Share by Region (2017-2028)
    Figure 57. China Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 60. India Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 62. Taiwan Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 66. Philippines Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Antibody-drug Conjugates Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Antibody-drug Conjugates Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Antibody-drug Conjugates Sales Share by Country (2017-2028)
    Figure 72. Latin America Antibody-drug Conjugates Revenue Share by Country (2017-2028)
    Figure 73. Mexico Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Antibody-drug Conjugates Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Antibody-drug Conjugates Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Antibody-drug Conjugates Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Antibody-drug Conjugates Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Antibody-drug Conjugates Revenue Share by Country (2017-2028)
    Figure 82. Turkey Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 84. U.A.E Antibody-drug Conjugates Revenue (2017-2028) & (US$ Million)
    Figure 85. Antibody-drug Conjugates Value Chain
    Figure 86. Antibody-drug Conjugates Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Torasemide API Market Research Report 2022
Global Torasemide API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-37B11450
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Baloxavir Marboxil API Market Research Report 2022
Global Baloxavir Marboxil API Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-39E11527
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2022
Global Veterinary Drug Grade Fluralaner Active Pharmaceutical Ingredient Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-29D11405
Fri Aug 12 00:00:00 UTC 2022

Add to Cart

Global Chemiluminescence Immunodiagnostic Market Research Report 2022
Global Chemiluminescence Immunodiagnostic Market Research Report 2022

120 Pages
Type: Report
Code: QYRE-Auto-18X11631
Fri Aug 12 00:00:00 UTC 2022

Add to Cart